The crystal 8-endotoxin of Bacillus thuringiensis subsp. israelensis is less toxic to larvae of Anopheles freeborni than to larvae of Aedes aegypti. However, when solubilized crystal was used, larvae from both species showed similar sensitivities. This effect presumably was due to the differences in feeding behavior between the two mosquito larvae when crystal preparations are used. A procedure is described whereby both crystal and solubilized B. thuringiensis subsp. israelensis toxin were emulsified with Freund incomplete adjuvant, with retention of toxicity. The use of Freund incomplete adjuvant also allowed one to assay the solubilized toxin at a low nanogram level. Furthermore, coating the toxin with lipophilic material altered the buoyancy of the toxin and reversed the sensitivities of the two mosquito larvae toward the B. thuringiensis subsp. israelensis toxin. This difference in buoyancy was determined by using an enzyme-linked immunosorbent assay that was specific for the toxic peptides. These data indicate that economically feasible buoyant formulations for the B. thuringiensis subsp. israelensis crystal can be developed.
The isolation of the bacterium Bacillus thuringiensis subsp. israelensis by Goldberg and Margalit (9) has generated a tremendous amount of enthusiasm for using this organism for biological control of mosquito and black-fly larvae. Subsequent studies have established that a crystalline toxin (8-endotoxin) is produced and released during sporulation of the bacterium (5, 13, 18) . After ingestion by susceptible hosts, the crystal is activated by the alkaline insect gut and exerts its effects on the gut epithelial cells (11, 12) . The specificity and potency of this toxin toward the mosquito and black-fly larvae have resulted in its recommendation by the World Health Organization for industrial production as a biological agent for the control of insect vectors for many tropical diseases (1) .
The crystal toxin is very effective against mosquito larvae such as Aedes aegypti, Culex pipiens, and Culex tarsalis. Fifty percent lethal concentrations are reported to be at the low nanogram levels (0.2 to 20 ng/ml) (15, 17, 19) . In contrast, larvae of Anopheles species are 50 to 100 times less sensitive when they are exposed to the crystal toxin. This effect presumably is due to the surface feeding behavior of the Anopheles species mosquito larvae rather than to some innate resistance of these animals (7, 9, 16) . It is believed that formulations that alter the buoyancy of the crystal toxin (or fermentation products) will result in concentrating the toxin just under the water surface, thus effectively exposing the larvae of Anopheles species to the toxin (9) . In addition, this process will release the toxin slowly into the water column, thus achieving long-term control. One such recent attempt was by coating corn crop granules with B. thuringiensis subsp. israelensis toxin (Bactimos Granular C; Biochem, Salsbury Lab Inc.). Also, solubilized B. thuringiensis subsp. israelensis toxin after centrifugation at 100,000 x g was shown to bind readily onto latex beads (0.8 ,um) with retention of toxicity (15) . This technique may prove to be an interesting approach for mosquito control when beads of varied buoyancy are used.
In this study, both crystal and soluble B. thuringiensis * Corresponding author.
subsp. israelensis toxin were encapsulated in micro-lipid droplets without the loss of toxicity. Results of bioassays are reported, and the economic implications of our findings are discussed.
MATERIALS AND METHODS Microorganism and growth conditions. B. thuringiensis subsp. israelensis (HD-567, Dulmage), obtained from Bruce Carlton at the University of Georgia, was designated HD-567-1 by Gonzalez and Carlton (10) . The organism was maintained on nutrient agar slant at 4°C and subcultured every 3 months. Cells for experimental use were cultured in modified GYS medium and collected as described previously (2) .
Purification and solubilization of crystal 8-endotoxin. B. thuringiensis subsp. israelensis crystal toxin was separated from the spores by a discontinuous sucrose density gradient of 50, 63, and 73% (wt/vol) sucrose in 0.03% Triton X-100. After the spore-crystal suspension was layered on top of the gradient (30 ml), it was centrifuged at 3,000 rpm for 30 min and then at 10,000 rpm for 2 h in a Sorvall swinging bucket rotor (HB-4). A band of bright, reflective crystals was formed at the interface of the 63 and 73% sucrose. The crystals were removed and washed three times with distilled water to remove the sucrose and Triton X-100. The pellet was then divided into working samples, lyophilized to dryness, weighed, and stored at -60°C.
To solubilize the toxin, the dry crystal was suspended in 0.5% sodium carbonate (pH 11.0) and 0.02% sodium azide for 3 h at 28°C with sonication at 30-min intervals. Nonsoluble matter was removed by centrifugation at 10,000 rpm for 30 min (Sorvall SS-34 rotor). The supernatant was dialyzed and used for bioassays.
Lipid-droplet encapsulation. Crystal suspension (5 mg wet wt/ml) or soluble toxin (1 mg/ml) was emulsified with an equal volume of Freund incomplete adjuvant (FIA) (Sigma Chemical Co.). The resulting emulsion was diluted 1:100 before the appropriate amount was assayed against the mosquito larvae. As a control, bovine serum albumin (1 mg/ml) was emulsified with FIA and assayed against larvae of all four mosquito species at 100 times the concentration of BACILLUS THURINGLENSIS FLOATING FORMULATION B. thuringiensis subsp. israelensis toxin to make sure that the FIA was not toxic toward the test animals. Efficiency of encapsulation. Suspension of intact crystals (5 mg/ml) were centrifuged at 1,000 rpm for 10 min. Samples of the crystal suspension (I), the pellet (II), and the supernatant (III) were stored at 4°C. A 0.5-ml sample of the crystal suspension was emulsified with an equal volume of FIA. The emulsion (1 ml) was then diluted with 20 ml of distilled water. A 10-ml sample of the emulsion suspension was centrifuged at 1,000 rpm for 10 min. The pellet (V), which consisted largely of nonencapsulated crystal, was stored at 4°C. The supernatant, which contained the encapsulated crystals (VI) and the other 10 ml of emulsion suspension (IV), was vortexed separately with 1 ml of hexane added to reduce the surface tension of the lipid droplets. The two fractions (IV and VI) were then centrifuged at 7,000 rpm for 45 min to break up the emulsion and to collect the crystals. All of the fractions, which included total crystal suspension (1), crystals (II), water-soluble proteins (III), total recoverable crystals from FIA (IV), nonencapsulated crystals (V), and encapsulated crystals (VI), were collected and then solubilized in a 0.5% sodium carbonate buffer. Appropriate dilutions were made and assayed for B. thuringiensis subsp. israelensis 5-endotoxin with an enzyme-linked immunosorbent assay (ELISA) procedure (20 Table 2 show that the FIA emulsion technique was very effective in encapsulating the B. thuringiensis subsp. israelensis crystals. After emulsion with FIA, about 3% of the total detectable toxins were recovered by low-speed centrifugation (1,000 rpm), and these were presumably not encapsulated in the lipid droplets. It also appears that the lipid droplets were very effective in retaining the encapsulated materials. Even after vortexing with hexane and centrifuging at high speed (7,000 rpm for 45 min), only about 30% of the total crystals were recovered. Microscopic examination of the remaining lipid layer indicated that it was still rich in crystals, whereas previous studies have shown that centrifugation pellets essentially all suspended crystals. Thus, most of the immunoreactive material which was not accounted for is probably encapsulated.
The buoyancy of the crystals is altered (increased) when they are coated with a lipophilic material. An ELISA specific for the marker proteins of the B. thuringiensis subsp. israelensis crystals (20) was used to show that >50% of the toxin was now concentrated near the water surface throughout the testing period (Fig. 1) . Either a slower sedimentation rate or a slow release mechanism from the lipid droplets maintained a higher concentration of toxin at the surface. In either case, a majority of the applied toxin remained at or near the water surface for 24 h and probably longer. In contrast, toxin preparations that were not coated with FIA sunk away from the water surface rapidly and distributed evenly throughout the water column within 15 min after application. When tested against mosquito larvae, the toxin micro-lipid droplets showed increased toxicity (20 times) toward the larvae ofAnopheles species, whereas those of the Aedes and Culex species showed a slight increase (2 to 3 times) in susceptibility. This increase was probably due to the presence of the lipid droplets of a size which promotes feeding and ingestion. Our data demonstrate that the apparent insensitivity of the larvae of Anopheles species is due to a behavior difference of these animals.
Toxicity decreased when larvae were tested against the solubilized crystals (Table 1) because mosquito larvae are filter feeders. Thus, the animals do not ingest the protein efficiently (15) in the soluble form; a higher concentration (200x to 500x) is needed to kill the larvae.
Emulsification of the soluble toxin with FIA resulted in an increase in the toxicity of the toxin ( Table 1) . The 50% lethal concentrations of the soluble toxin-FIA emulsions are at the low nanogram level, closer to those of the crystals. Because the soluble toxin was encapsulated in lipid droplets, the (Table 2) . mosquito larvae would ingest the droplets and the toxin along with them. Microscopic examination of the crystal-FIA emulsion revealed that crystals were indeed present within the lipid droplets ( Fig. 2A) . Furthermore, the diameters of the droplets varied from a few microns up to about 20 ,um, with greater than 50% of the droplets in between 10 and 5 ,um (Fig. 2B) , the appropriate ingestion size for late-instar mosquito larvae (4, 14) . Like the lipid-coated crystals, the soluble toxin-FIA preparations had similar toxicity toward the Anopheles species mosquito larvae when compared with the other three species of mosquitoes. The floating lipid droplets created easy access to the toxin for the surfacefeeding Anopheles species and the column-feeding Culex species larvae, but not the bottom-feeding Aedes larvae, which showed an approximately eightfold decrease in toxicity when compared with the crystals. These data indicate that further specificity and efficacy for a given species or age cohort in synchronous populations could be obtained by varying the particle size.
Research to elucidate the mode of action of the B. thuringiensis subsp. israelensis 8-endotoxin has long been hampered by the lack of a sensitive bioassay. The (7) .
Presumably, efficacy is lost once the crystals settle into the mud, where the toxin is digested rapidly by soil microorganisms. Although microbial degradation was suspected as a major cause of lost efficacy, there have been few systematic approaches directed at this problem. In some of our preliminary studies, we have shown that even in nonpolluted water, the biological activity of the B. thuringiensis subsp. israelensis organisms deteriorated rapidly (a 75% loss within 24 h). This is not surprising because the crystal toxin, being of proteinaceous nature, is an excellent food source for microorganisms. It can be readily digested when it settles into the sediment where microorganisms thrive. Mosquito larvae feeding off the bottom will therefore have a short time period to accumulate the active toxin after it is applied.
Our study has shown that encapsulating the toxin in micro-lipid droplets is a workable system to keep the toxin afloat, and therefore efficacy may be prolonged. With the recent advancement in liposome technology, liposomes with different buoyancies can be engineered to carry the B. thuringiensis subsp. israelensis toxin, targeting mosquito larvae of all species. Furthermore, antimicrobial agents can be incorporated into the complex to discourage microorganisms from attacking the lipid-and protein-rich complex. Even sunscreen (a lipophilic compound) can be incorporated to protect the toxin from UV light, since some investigators have claimed that the toxin is sunlight sensitive.
In conclusion, the method described in this paper for formulating B. thuringiensis subsp. israelensis toxin has wide application for both mosquito research and abatement. At its most limited use, it can be employed to assay soluble toxin at very low concentrations. At its best, it may widen the effective spectrum of B. thuringiensis subsp. israelensis toxin to all mosquito species.
